Literature DB >> 23949494

Phenotype/genotype correlation in a case series of Stargardt's patients identifies novel mutations in the ABCA4 gene.

M Gemenetzi1, A J Lotery.   

Abstract

PURPOSE: To investigate phenotypic variability in terms of best-corrected visual acuity (BCVA) in patients with Stargardt disease (STGD) and confirmed ABCA4 mutations.
METHODS: Entire coding region analysis of the ABCA4 gene by direct sequencing of seven patients with clinical findings of STGD seen in the Retina Clinics of Southampton Eye Unit between 2002 and 2011.Phenotypic variables recorded were BCVA, fluorescein angiographic appearance, electrophysiology, and visual fields.
RESULTS: All patients had heterozygous amino acid-changing variants (missense mutations) in the ABCA4 gene. A splice sequence change was found in a 30-year-old patient with severly affected vision. Two novel sequence changes were identified: a missense mutation in a mildly affected 44-year-old patient and a frameshift mutation in a severly affected 34-year-old patient.
CONCLUSION: The identified ABCA4 mutations were compatible with the resulting phenotypes in terms of BCVA. Higher BCVAs were recorded in patients with missense mutations. Sequence changes, predicted to have more deleterious effect on protein function, resulted in a more severe phenotype. This case series of STGD patients demonstrates novel genotype/phenotype correlations, which may be useful to counselling of patients. This information may prove useful in selection of candidates for clinical trials in ABCA4 disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23949494      PMCID: PMC3831132          DOI: 10.1038/eye.2013.176

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  10 in total

1.  An analysis of allelic variation in the ABCA4 gene.

Authors:  A R Webster; E Héon; A J Lotery; K Vandenburgh; T L Casavant; K T Oh; G Beck; G A Fishman; B L Lam; A Levin; J R Heckenlively; S G Jacobson; R G Weleber; V C Sheffield; E M Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-05       Impact factor: 4.799

2.  The spectrum of retinal phenotypes caused by mutations in the ABCA4 gene.

Authors:  B Jeroen Klevering; August F Deutman; Alessandra Maugeri; Frans P M Cremers; Carel B Hoyng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-22       Impact factor: 3.117

3.  Analysis of the ABCA4 gene by next-generation sequencing.

Authors:  Jana Zernant; Carl Schubert; Kate M Im; Tomas Burke; Carolyn M Brown; Gerald A Fishman; Stephen H Tsang; Peter Gouras; Michael Dean; Rando Allikmets
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-31       Impact factor: 4.799

Review 4.  The rod photoreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from monogenic to multifactorial.

Authors:  N F Shroyer; R A Lewis; R Allikmets; N Singh; M Dean; M Leppert; J R Lupski
Journal:  Vision Res       Date:  1999-07       Impact factor: 1.886

5.  Null missense ABCR (ABCA4) mutations in a family with stargardt disease and retinitis pigmentosa.

Authors:  N F Shroyer; R A Lewis; A N Yatsenko; J R Lupski
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-11       Impact factor: 4.799

6.  The 2588G-->C mutation in the ABCR gene is a mild frequent founder mutation in the Western European population and allows the classification of ABCR mutations in patients with Stargardt disease.

Authors:  A Maugeri; M A van Driel; D J van de Pol; B J Klevering; F J van Haren; N Tijmes; A A Bergen; K Rohrschneider; A Blankenagel; A J Pinckers; N Dahl; H G Brunner; A F Deutman; C B Hoyng; F P Cremers
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

7.  A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy.

Authors:  R Allikmets; N Singh; H Sun; N F Shroyer; A Hutchinson; A Chidambaram; B Gerrard; L Baird; D Stauffer; A Peiffer; A Rattner; P Smallwood; Y Li; K L Anderson; R A Lewis; J Nathans; M Leppert; M Dean; J R Lupski
Journal:  Nat Genet       Date:  1997-03       Impact factor: 38.330

8.  Genotype-phenotype correlation in Italian families with Stargardt disease.

Authors:  Francesca Simonelli; Francesco Testa; Jana Zernant; Anna Nesti; Settimio Rossi; Rando Allikmets; Ernesto Rinaldi
Journal:  Ophthalmic Res       Date:  2005-05-07       Impact factor: 2.892

9.  Genotyping microarray (gene chip) for the ABCR (ABCA4) gene.

Authors:  K Jaakson; J Zernant; M Külm; A Hutchinson; N Tonisson; D Glavac; M Ravnik-Glavac; M Hawlina; M R Meltzer; R C Caruso; F Testa; A Maugeri; C B Hoyng; P Gouras; F Simonelli; R A Lewis; J R Lupski; F P M Cremers; R Allikmets
Journal:  Hum Mutat       Date:  2003-11       Impact factor: 4.878

10.  Genotype/Phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease.

Authors:  R A Lewis; N F Shroyer; N Singh; R Allikmets; A Hutchinson; Y Li; J R Lupski; M Leppert; M Dean
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

  10 in total
  2 in total

Review 1.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

2.  Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5.

Authors:  Maria A Parker; Laura R Erker; Isabelle Audo; Dongseok Choi; Saddek Mohand-Said; Kastytis Sestakauskas; Patrick Benoit; Terence Appelqvist; Melissa Krahmer; Caroline Ségaut-Prévost; Brandon J Lujan; Ambar Faridi; Elvira N Chegarnov; Peter N Steinkamp; Cristy Ku; Mariana Matioli da Palma; Pierre-Olivier Barale; Sarah Ayelo-Scheer; Andreas Lauer; Tim Stout; David J Wilson; Richard G Weleber; Mark E Pennesi; José Alain Sahel; Paul Yang
Journal:  Am J Ophthalmol       Date:  2022-03-04       Impact factor: 5.488

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.